Cardiovascular Systems Inc (CSII) - Product Pipeline Analysis, 2018 Update

Summary

Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The companys products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for occlusive atherosclerotic disease in peripheralarteries and stenotic material from artificial arteriovenous dialysis fistulae. CSI offers accessories such as guide wire, lubricant, pump and tape. It has developed orbital atherectomy systems technology for both peripheral and coronary commercial applications. The company serves patients suffering from peripheral arterial disease and coronary artery diseases. It markets its products through its network of distributors. CSI is headquartered in St. Paul, Minnesota, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Cardiovascular Systems Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



List of Tables 3
List of Figures 3
Cardiovascular Systems Inc Company Overview 4
Cardiovascular Systems Inc Company Snapshot 4
Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Cardiovascular Systems Inc Pipeline Analysis Overview 7
Cardiovascular Systems Inc - Key Facts 7
Cardiovascular Systems Inc - Major Products and Services 8
Cardiovascular Systems Inc Pipeline Products by Development Stage 9
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status 11
Cardiovascular Systems Inc Pipeline Products Overview 13
Diamondback 360 Peripheral Orbital Atherectomy System 13
Diamondback 360 Peripheral Orbital Atherectomy System Product Overview 13
Diamondback 360 Peripheral Orbital Atherectomy System Clinical Trial 14
Second Generation Diamondback 360 Coronary Orbital Atherectomy System 16
Second Generation Diamondback 360 Coronary Orbital Atherectomy System Product Overview 16
Second Generation Diamondback 360 Coronary Orbital Atherectomy System Clinical Trial 17
ZILIENT Guidewire - Coronary Intervention 18
ZILIENT Guidewire - Coronary Intervention Product Overview 18
ZILIENT Guidewire - Radial Peripheral Intervention 19
ZILIENT Guidewire - Radial Peripheral Intervention Product Overview 19
Cardiovascular Systems Inc - Key Competitors 20
Cardiovascular Systems Inc - Key Employees 21
Cardiovascular Systems Inc - Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Cardiovascular Systems Inc, Recent Developments 23
Jul 16, 2018: Cardiovascular Systems Signs International Distribution Agreement with OrbusNeich 23
May 02, 2018: Cardiovascular Systems Reports Fiscal 2018 Third-Quarter Financial Results 23
Mar 06, 2018: Cardiovascular Systems Presents LIBERTY 360 18-Month Outcomes at CRT18 Interventional Cardiology Conference 25
Feb 26, 2018: Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX AR-V7 Nucleus Detect Test to Predict Treatment Response in Metastatic Disease 25
Feb 23, 2018: Holy Cross Hospital is One of the First to Use New DIAMONDBACK 360 CORONARY OAS Technology for Treatment of Coronary Artery Disease 26
Feb 16, 2018: QSpine Receives CE Mark Certification for SURE Single Use Illuminated Retractor System 26
Feb 14, 2018: Cardiovascular Systems Announces First Patients Treated from Radial Access Using Its Diamondback 360 Extended Length Peripheral Orbital Atherectomy Device 27
Feb 07, 2018: Cardiovascular Systems Reports Fiscal 2018 Second-Quarter Financial Results 28
Feb 02, 2018: Cardiovascular Systems Appoints Jeff Points as Chief Financial Officer 29
Feb 01, 2018: Cardiovascular Systems Announces Commercial Launch in Japan 29
Appendix 31
Methodology 31
About GlobalData 34
Contact Us 34
Disclaimer 34

List Of Tables


Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Cardiovascular Systems Inc Pipeline Products by Equipment Type 5
Cardiovascular Systems Inc Pipeline Products by Indication 6
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status 6
Cardiovascular Systems Inc, Key Facts 7
Cardiovascular Systems Inc, Major Products and Services 8
Cardiovascular Systems Inc Number of Pipeline Products by Development Stage 9
Cardiovascular Systems Inc Pipeline Products Summary by Development Stage 10
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status 11
Cardiovascular Systems Inc Ongoing Clinical Trials Summary 12
Diamondback 360 Peripheral Orbital Atherectomy System - Product Status 13
Diamondback 360 Peripheral Orbital Atherectomy System - Product Description 13
Diamondback 360 Peripheral Orbital Atherectomy System - Diamondback Atherectomy with OCT Visualization for Calcified PAD Lesions for Calcified Peripheral Vascular Disease Lesions 14
Diamondback 360 Peripheral Orbital Atherectomy System - Directional Versus Orbital Atherectomy Plaque Modification and Luminal Area Assessment of the Femoro-popliteal Artery Via Intravascular Ultrasound 14
Diamondback 360 Peripheral Orbital Atherectomy System - Orbital Vessel Preparation to Maximize DCB Efficacy in Calcified below the Knee (BTK) Lesions - A Pilot Study 14
Diamondback 360 Peripheral Orbital Atherectomy System - Prospective, Observational, Multi-center Clinical Study to Evaluate Acute and Long Term Clinical and Economic Outcomes of Endovascular Device Intervention in Patients with Distal Outflow Peripheral Arterial Disease (PAD): LIBERTY 360 15
Second Generation Diamondback 360 Coronary Orbital Atherectomy System - Product Status 16
Second Generation Diamondback 360 Coronary Orbital Atherectomy System - Product Description 16
Second Generation Diamondback 360 Coronary Orbital Atherectomy System - Comparison of Orbital Versus Rotational Atherectomy Effects on Coronary Microcirculation in Percutaneous Coronary Intervention (PCI) 17
Second Generation Diamondback 360 Coronary Orbital Atherectomy System - Evaluation of Treatment Strategies for Severe CalcIfic Coronary Arteries: Orbital Atherectomy versus Conventional Angioplasty Technique Prior to Implantation of Drug-eluting Stents: The ECLIPSE Trial 17
ZILIENT Guidewire - Coronary Intervention - Product Status 18
ZILIENT Guidewire - Coronary Intervention - Product Description 18
ZILIENT Guidewire - Radial Peripheral Intervention - Product Status 19
ZILIENT Guidewire - Radial Peripheral Intervention - Product Description 19
Cardiovascular Systems Inc, Key Employees 21
Glossary 33

List Of Figures


Cardiovascular Systems Inc Pipeline Products by Equipment Type 5
Cardiovascular Systems Inc Pipeline Products by Development Stage 9
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status 11

Global and Southeast Asia Cardiovascular ultrasound imaging systems Industry, 2018 Market Research Report

The Global and Southeast Asia Cardiovascular Ultrasound Imaging Systems Industry, 2013-2023 Market Research Report is a professional and in-depth study on the current state of the global Cardiovascular Ultrasound Imaging

USD 3000 View Report

Global and Southeast Asia Cardiovascular guidewires Industry, 2018 Market Research Report

The Global and Southeast Asia Cardiovascular Guidewires Industry, 2013-2023 Market Research Report is a professional and in-depth study on the current state of the global Cardiovascular Guidewires industry with a

USD 3000 View Report

Akonni Biosystems Inc - Product Pipeline Analysis, 2018 Update

Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company provides product such as nucleic acid extraction kits, molecular

USD 750 View Report

Ra Medical Systems Inc (RMED) - Medical Equipment - Deals and Alliances Profile

Ra Medical Systems Inc (Ra Medical Systems) is a medical device company that develops, designs, and commercializes excimer laser systems for the treatment of cardiovascular and dermatologic diseases. The companys

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available